Le discours de l'innovation technologique en médecine régénératrice
This dissertation discusses the idea of technological innovation in regenerative medicine in Canada. While this potentially groundbreaking therapy is publicly funded and at an early stage of the understanding of cellular processes, the analysis shows that it is already concerned with the marketing of the scientific work. This raises questions about how public laboratories framed by a scientific research closely tied up with economic concerns and with a shift in the role of the State carry speculation and lead to a technological oriented production of knowledge. This writing doesn’t debate science as a mean or science as an end. It is rather about the extension of the economic reasoning. Indeed, the market’s reading grid as the starting point is the story of the hegemony of a specific logic which turns regenerative medicine research into an economic venture.
science technological innovation regenerative medicine